These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 12415808)
21. [Development of a new tubulin-interacting agent, docetaxel (taxotere) in Japan]. Tsukagoshi S Gan To Kagaku Ryoho; 1997 Jul; 24(9):1167-74. PubMed ID: 9239173 [TBL] [Abstract][Full Text] [Related]
22. Docetaxel in the management of advanced non-small cell lung cancer. Miller VA Semin Oncol; 1998 Jun; 25(3 Suppl 8):15-9. PubMed ID: 9704671 [TBL] [Abstract][Full Text] [Related]
23. [Phase II study]. Niitani H Gan To Kagaku Ryoho; 1995 Apr; 22(5):607-10. PubMed ID: 7717711 [TBL] [Abstract][Full Text] [Related]
24. [Chemotherapy of solid tumors: pharmacologic activity or effectiveness?]. Longo F; Mansueto G Tumori; 1999; 85(6):A26-33. PubMed ID: 10774584 [No Abstract] [Full Text] [Related]
32. The development of docetaxel (Taxotere) in non-small cell lung cancer--docetaxel in new combinations and new schedules: an overview of ongoing and future developments. Donnellan PP; Crown JP Semin Oncol; 1997 Aug; 24(4 Suppl 14):S14-18-S14-21. PubMed ID: 9335519 [TBL] [Abstract][Full Text] [Related]
33. Sensitivity of non-small-cell lung cancer cell lines established from patients treated with prolonged infusions of Paclitaxel. Fujishita T; Loda M; Turner RE; Gentler M; Kashii T; Breathnach OS; Johnson BE Oncology; 2003; 64(4):399-406. PubMed ID: 12759538 [TBL] [Abstract][Full Text] [Related]
34. Docetaxel (Taxotere) and neoadjuvant chemotherapy for non-small cell lung cancer. Mattson K Semin Oncol; 1999 Jun; 26(3 Suppl 10):25-8. PubMed ID: 10437748 [TBL] [Abstract][Full Text] [Related]
35. Docetaxel for locally advanced or metastatic non-small-cell lung cancer. Current data and future directions as front-line therapy. Khuri FR Oncology (Williston Park); 2002 Jun; 16(6 Suppl 6):53-62. PubMed ID: 12108898 [TBL] [Abstract][Full Text] [Related]
37. [Taxenes: a new hope of clinical oncology in the 90-ies]. Shparik IV Vopr Onkol; 1995; 41(1):7-12. PubMed ID: 7667946 [No Abstract] [Full Text] [Related]
38. New chemotherapeutic agents in non-small-cell lung cancer. Feigal EG; Christian M; Cheson B; Grever M; Friedman MA Semin Oncol; 1993 Apr; 20(2):185-201. PubMed ID: 7683142 [No Abstract] [Full Text] [Related]
39. [Early phase II study of BMS-181339 (paclitaxel) in patients with non-small cell lung cancer. BMS-181339 Non-Small Cell Lung Cancer Study Group]. Yoneda S; Nishiwaki Y; Niitani H; Kurita Y; Ariyoshi Y; Ikegami H; Furuse K; Fukuoka M; Kimura I; Hara N; Saijo N Gan To Kagaku Ryoho; 1996 May; 23(6):695-701. PubMed ID: 8645020 [TBL] [Abstract][Full Text] [Related]
40. [Docetaxel in lymphangiosis carcinomatosa]. Pestalozzi BC Schweiz Med Wochenschr; 1997 May; 127(19):839. PubMed ID: 9244987 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]